Stocktoria
Nurix Therapeutics, Inc. NRIX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-07-24
Nurix Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 6,820,015 | $142.3M |
| ARK Investment Management LLC | 1,721,135 | $26.7M |
| CITADEL ADVISORS LLC | 1,380,300 | $21.4M |
| MILLENNIUM MANAGEMENT LLC | 546,297 | $8.5M |
| Point72 Asset Management, L.P. | 449,106 | $7.0M |
| D. E. Shaw & Co., Inc. | 344,203 | $5.3M |
| RENAISSANCE TECHNOLOGIES LLC | 118,000 | $1.8M |
| AQR CAPITAL MANAGEMENT LLC | 16,406 | $254,294 |
Source: SEC EDGAR filings · CIK 0001549595 · as of 2025-11-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.